Hearables: feasibility of recording cardiac rhythms from single in-ear locations.

The ear is well positioned to accommodate both brain and vital signs monitoring, via so-called hearable devices. Consequently, ear-based electroencephalography has recently garnered great interest. However, despite the considerable potential of hearable based cardiac monitoring, the biophysics and characteristic cardiac rhythm of ear-based electrocardiography (ECG) are not yet well understood. To this end, we map the cardiac potential on the ear through volume conductor modelling and measurements on multiple subjects. In addition, in order to demonstrate real-world feasibility of in-ear ECG, measurements are conducted throughout a long-time simulated driving task. As a means of evaluation, the correspondence between the cardiac rhythms obtained via the ear-based and standard Lead I measurements, with respect to the shape and timing of the cardiac rhythm, is verified through three measures of similarity: the Pearson correlation, and measures of amplitude and timing deviations. A high correspondence between the cardiac rhythms obtained via the ear-based and Lead I measurements is rigorously confirmed through agreement between simulation and measurement, while the real-world feasibility was conclusively demonstrated through efficacious cardiac rhythm monitoring during prolonged driving. This work opens new avenues for seamless, hearable-based cardiac monitoring that extends beyond heart rate detection to offer cardiac rhythm examination in the community.

Vaccination status of COVID-19 patients followed up in the ICU in a country with heterologous vaccination policy: A multicenter national study in Turkey.

OBJECTIVE: Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-2) prevents the development of serious diseases has been shown in many studies. However, the effect of vaccination on outcomes in COVID-19 patients requiring intensive care is not clear. METHODS: This is a retrospective multicenter study conducted in 17 intensive care unit (ICU) in Turkey between January 1, 2021, and December 31, 2021. Patients aged 18 years and older who were diagnosed with COVID-19 and followed in ICU were included in the study. Patients who have never been vaccinated and patients who have been vaccinated with a single dose were considered unvaccinated. Logistic regression models were fit for the two outcomes (28-day mortality and in-hospital mortality). RESULTS: A total of 2968 patients were included final analysis. The most of patients followed in the ICU during the study period were unvaccinated (58.5%). Vaccinated patients were older, had higher Charlson comorbidity index (CCI), and had higher APACHE-2 scores than unvaccinated patients. Risk for 28-day mortality and in-hospital mortality was similar in across the year both vaccinated and unvaccinated patients. However, risk for in-hospital mortality and 28-day mortality was higher in the unvaccinated patients in quarter 4 adjusted for gender and CCI (OR: 1.45, 95% CI: 1.06-1.99 and OR: 1.42, 95% CI: 1.03-1.96, respectively) compared to the vaccinated group. CONCLUSION: Despite effective vaccination, fully vaccinated patients may be admitted to ICU because of disease severity. Unvaccinated patients were younger and had fewer comorbid conditions. Unvaccinated patients have an increased risk of 28-day mortality when adjusted for gender and CCI.

Ear-EEG sensitivity modeling for neural sources and ocular artifacts.

The ear-EEG has emerged as a promising candidate for real-world wearable brain monitoring. While experimental studies have validated several applications of ear-EEG, the source-sensor relationship for neural sources from across the brain surface has not yet been established. In addition, modeling of the ear-EEG sensitivity to sources of artifacts is still missing. Through volume conductor modeling, the sensitivity of various configurations of ear-EEG is established for a range of neural sources, in addition to ocular artifact sources for the blink, vertical saccade, and horizontal saccade eye movements. Results conclusively support the introduction of ear-EEG into conventional EEG paradigms for monitoring neural activity that originates from within the temporal lobes, while also revealing the extent to which ear-EEG can be used for sources further away from these regions. The use of ear-EEG in scenarios prone to ocular artifacts is also supported, through the demonstration of proportional scaling of artifacts and neural signals in various configurations of ear-EEG. The results from this study can be used to support both existing and prospective experimental ear-EEG studies and applications in the context of sensitivity to both neural sources and ocular artifacts.

Hearables: Feasibility and Validation of In-Ear Electrocardiogram.

Out-of-clinic, continuous monitoring of vital signs is envisaged to become the backbone of future e-health. The emerging wrist worn devices have already proven to be a success in the measurement of pulse, however, a susceptibility to artefacts and missing data caused by regular motion in everyday activities, and the inability to continuously acquire the electrocardiogram call into question the utility of this technology in future e-Health. With this in mind, the head, and in particular the ear canals, have been investigated as possible locations for wearable devices. The ears offer a stable position relative to the vital signs during everyday activities, such as sitting, walking, running and sleeping, as well as being a practical and widely accepted base for wearable accessories. This all suggests that the ear canals are a most natural location for physiological sensing in the community. This work addresses the feasibility of recording the ECG from the ear canals, from a one-fits-all, user-friendly device. For rigour and clarity, we quantitatively compare the timings of the identified P-, QRS-, and T-waves within Ear-ECG and standard arm-ECG. Finally, to depict a future e-Health scenario for the Ear-ECG technology, a case study with an abnormal heart condition, the ventricular bigeminy, is presented. A comprehensive study over ten subjects demonstrates conclusively the possibility of in-ear cardiac monitoring in normal daily life.